Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05439408 Org: User:
Start: 06/07/21 End: 06/25/21 Due: 06/25/22

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05967377 Org: User:
Start: 11/16/18 End: 02/12/19 Due: 02/12/20

An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL®

Phase: N/A Priority: Normal
NCT ID: NCT06145217 Org: User:
Start: 08/22/23 End: 08/29/23 Due: 08/29/24

Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05433896 Org: User:
Start: 11/01/20 End: 12/19/20 Due: 12/19/21